Apolipoprotein E Mediates the Retention of High-Density Lipoproteins by Mouse Carotid Arteries and Cultured Arterial Smooth Muscle Cell Extracellular Matrices
Abstract
Lipoprotein retention in the vascular extracellular matrix (ECM) plays a critical role in atherogenesis. Previous studies demonstrated the presence of apo A-I and E in atherosclerotic lesions, suggesting that HDL may be trapped by the artery wall. We sought to determine mechanisms by which HDL could be bound and retained by the arterial wall, and whether apo E was a principal determinant of this binding. We evaluated in situ accumulation of fluorescently labeled DiI-human HDL±apo E in perfused carotid arteries from apo E–null mice. Apo E was important in mediating HDL binding to the vascular wall, with a 48±16% increase in accumulation of DiI-labeled apo E–containing HDL (HDL 3 +E) compared with DiI-apo E–free HDL (HDL 3 −E) ( P =0.003). To investigate possible mechanisms responsible for retention, we assessed binding of unlabeled HDL 3 −E and HDL 3 +E to ECM generated by cultured arterial smooth muscle cells. Similar to the in situ carotid artery data, HDL 3 +E bound better to the ECM than did HDL 3 −E (3-fold lower K a and 3.5-fold higher B max for HDL 3 +E versus HDL 3 −E). These differences were eliminated after either neutralization of arginine residues on apo E or digestion of matrix with chondroitin ABC lyase, suggesting that chondroitin and/or dermatan sulfate proteoglycans were responsible for apo E–mediated increased binding. These findings demonstrate that HDL can bind to both intact murine carotid arteries and smooth muscle cell–derived ECM, and that apo E is a principal determinant in mediating the ability of HDL to be trapped and retained via its interaction with ECM proteoglycans.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The binding of apoE to cell-surface glycosaminoglycans (GAG) such as chondroitin sulfate (CS) and dermatan sulfate (DS) proteoglycans plays an important role in lipoprotein catabolism.
“Besides the apoE-HSPG interaction, the binding of apoE to cell-surface glycosaminoglycans (GAG) such as chondroitin sulfate (CS) and dermatan sulfate (DS) proteoglycans has been demonstrated to play an important role in lipoprotein catabolism.”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [14]
Interaction of apoE with CS and/or DS proteoglycans is responsible for the retention of HDL on the extracellular matrix of arterial smooth muscle cells.
“the interaction of apoE with CS and/or DS proteoglycans is responsible for the retention of HDL on the extracellular matrix of arterial smooth muscle cells (14).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [14]
Cites
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028 · see citing works
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413 · see citing works
Enzymatic Methods for the Determination of Small Quantities of Isomeric Chondroitin Sulfates
Saito, H., Yamagata, T., & Suzuki, S. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93575-1 · Cited by 1,369 · see citing works
Molecular modeling of protein-glycosaminoglycan interactions.
Cardin, A. D., & Weintraub, H. J. R. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.1.21 · Cited by 1,301 · see citing works
Miyata, M., & Smith, J. D. (1996) · Nature Genetics · doi:10.1038/ng0996-55 · Cited by 889 · see citing works
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
Heinecke, J. W., Baker, L., Rosen, H., & Chait, A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112371 · Cited by 517 · see citing works
Self-citationSacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490 · see citing works
Pitas, R. E., Innerarity, T. L., Weinstein, J. N., & Mahley, R. W. (1981) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.1.3.177 · Cited by 389 · see citing works
Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques
O’Brien, K. D., Olin, K. L., Alpers, C. E., Chiu, W. S., Ferguson, M. S., Hudkins, K. L., Wight, T. N., & Chait, A. (1998) · Circulation · doi:10.1161/01.cir.98.6.519 · Cited by 271 · see citing works
Self-citationCamejo, G. (1982) · Advances in lipid research · doi:10.1016/b978-0-12-024919-0.50007-2 · Cited by 231 · see citing works
Camejo, G., Olofsson, S. ‐., Lopez, F., Carlsson, P., & Bondjers, G. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.4.368 · Cited by 198 · see citing works
Lipoprotein-receptor interactions
Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)29091-6 · Cited by 186 · see citing works
Ji, Z.-S., Dichek, H. L., Miranda, R. D., & Mahley, R. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31285 · Cited by 156 · see citing works
Pepe, M. G., & Curtiss, L. K. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3716 · Cited by 148 · see citing works
Camejo, G., Fager, G., Rosengren, B. E., Hurt‐Camejo, E., & Bondjers, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85218-3 · Cited by 143 · see citing works
Hollander, W. (1976) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(76)90021-6 · Cited by 122 · see citing works
Thorngate, F. E., Rudel, L. L., Walzem, R. L., & Williams, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1939 · Cited by 114 · see citing works
Rutledge, J. C., Woo, M. M., Rezai, A. A., Curtiss, L. K., & Goldberg, I. J. (1997) · Circulation Research · doi:10.1161/01.res.80.6.819 · Cited by 101 · see citing works
Self-citationLinton, M. F., Hasty, A. H., Babaev, V. R., & Fazio, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2181 · Cited by 100 · see citing works
Hazen, S. L., Gaut, J. P., Hsu, F., Crowley, J. R., d'Avignon, A., & Heinecke, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16990 · Cited by 83 · see citing works
Boisvert, W. A., Black, A. S., & Curtiss, L. K. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.525 · Cited by 64 · see citing works
Nakajima, T., Origuchi, N., Matsunaga, T., Kawai, S.-I., Hokari, S., Nakamura, H., Inoue, I., Katayama, S., Nagata, A., & Komoda, T. (2000) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563001899186 · Cited by 58 · see citing works
ApoE in Atherosclerosis: A Protein With Multiple Hats
Curtiss, L. K. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1852 · Cited by 55 · see citing works
Choi, S. Y., Pillarisetti, S., Walker, D. E., Curtiss, L. K., Gretch, D. G., Sturley, S. L., Attie, A., Deckelbaum, R. J., & Goldberg, I. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8081 · Cited by 54 · see citing works
Edwards, I., Ij, G., Parks, J. S., Xu, H., & Wagner, W. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37703-8 · Cited by 52 · see citing works
Camejo, G., Rosengren, B. E., Olson, U., Lopez, F., Olofson, S.-O., Westerlund, C., & Bondjers, G. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_e.164 · Cited by 50 · see citing works
Ville, A. E. L., Solà, R., Balanyà, J., TURNER, P. R., & Masana, L. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90048-5 · Cited by 49 · see citing works
Biglycan, a Vascular Proteoglycan, Binds Differently to HDL 2 and HDL 3
Olin, K. L., Potter‐Perigo, S., Barrett, P. H. R., Wight, T. N., & Chait, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.129 · Cited by 45 · see citing works
Self-citationOxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices
Chang, M. Y., Potter‐Perigo, S., Wight, T. N., & Chait, A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31645-x · Cited by 28 · see citing works
Self-citationVoyta, J. C., Via, D. P., Kinnunen, P. K. J., Sparrow, J. T., Gotto, A. M., & Smith, L. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71183-x · Cited by 27 · see citing works
Fish Apolipoprotein‐A‐I Has Heparin Binding Activity: Implication for Nerve Regeneration
Harel, A., FAINARU, M., Rubinstein, M., Tal, N., & Schwartz, M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb03130.x · Cited by 25 · see citing works
Paradis, V., Mathurin, P., Ratziu, V., Poynard, T., & Bédossa, P. (1996) · Hepatology · doi:10.1002/hep.510230543 · Cited by 25 · see citing works
Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries.
Bédossa, P., Poynard, T., Abella, A., Paraf, F., Lemaigre, G., & Martin, E. M. (1989) · PubMed · Cited by 24 · see citing works
Solvent drag of LDL across mammalian endothelial barriers with increased permeability
Rutledge, J., CURRY, F. E., Blanche, P. J., & Krauss, R. M. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.5.h1982 · Cited by 23 · see citing works
Self-citationKlezovitch, O., Formato, M., Cherchi, G. M., Weisgraber, K. H., & Scanu, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909644199 · Cited by 17 · see citing works
Apolipoprotein localization in human cranial arteries, coronary arteries, and the aorta.
Hoff, H. F. (1976) · Stroke · doi:10.1161/01.str.7.4.390 · Cited by 14 · see citing works
Immunohistochemical localization of apolipoproteins A–I and B in human carotid arteries
Carter, R. S., Siegel, R. J., Chai, A. U., & Fishbein, M. C. (1987) · The Journal of Pathology · doi:10.1002/path.1711530105 · Cited by 14 · see citing works
Evidence for an interaction of lipoprotein lipase with artery wall proteoglycans
Margelin, D., Pigier, A.-M., Gardette, J., Bertrand, J., Vu‐Dac, N., & Picard, J. (1989) · International Journal of Biochemistry · doi:10.1016/0020-711x(89)90208-5 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chait, A., Han, C. Y., Oram, J. F., & Heinecke, J. W. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400017-jlr200 · Cited by 230 · see citing works
Self-citationArterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 200 · see citing works
A brief elevation of serum amyloid A is sufficient to increase atherosclerosis
Thompson, J. C., Jayne, C., Thompson, J., Wilson, P. G., Yoder, M. H., Webb, N. R., & Tannock, L. R. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m054015 · Cited by 89 · see citing works
The effects of apolipoprotein B depletion on HDL subspecies composition and function
Davidson, W. S., Heink, A., Sexmith, H., Melchior, J., Gordon, S. M., Kuklenyik, Z., Woollett, L. A., Barr, J. R., Jones, J. I., Toth, C. A., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m066613 · Cited by 67 · see citing works
Chiba, T., Chang, M. Y., Wang, S., Wight, T. N., McMillen, T. S., Oram, J. F., Vaisar, T., Heinecke, J. W., de Beer, F. C., de Beer, M. C., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226159 · Cited by 61 · see citing works
Self-citationProteoglycan mediated lipoprotein retention: A mechanism of diabetic atherosclerosis
Tannock, L. R., & King, V. L. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9078-0 · Cited by 57 · see citing works
Yamauchi, Y., Deguchi, N., Takagi, C., Tanaka, M., Dhanasekaran, P., Nakano, M., Handa, T., Phillips, M. C., Lund-Katz, S., & Saito, H. (2008) · Biochemistry · doi:10.1021/bi8003999 · Cited by 53 · see citing works
Disturbed Laminar Blood Flow Vastly Augments Lipoprotein Retention in the Artery Wall
Steffensen, L. B., Mortensen, M. B., Kjølby, M., Hagensen, M. K., Oxvig, C., & Bentzon, J. F. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305874 · Cited by 35 · see citing works
Desgagné, V., Guérin, R., Guay, S., Corbin, F., Couture, P., Lamarche, B., & Bouchard, L. (2017) · Epigenomics · doi:10.2217/epi-2016-0177 · Cited by 26 · see citing works
Thorngate, F. E., Yancey, P. G., Kellner-Weibel, G., Rudel, L. L., Rothblat, G. H., & Williams, D. L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300224-jlr200 · Cited by 25 · see citing works
Mullick, A. E., Deckelbaum, R. J., Goldberg, I. J., Al-Haideri, M. T., & Rutledge, J. C. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040221.70377.19 · Cited by 24 · see citing works
Self-citationvon Ballmoos, M. C. W., Dubler, D., Mirlacher, M., Cathomas, G., Muser, J., & Biedermann, B. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000198250.91406.6d · Cited by 19 · see citing works
Oxidized plasma high-density lipoprotein is decreased in Alzheimer's disease
Bergt, C., Nakano, T., Ditterich, J., DeCarli, C. S., & Eiserich, J. P. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.019 · Cited by 13 · see citing works
Barazza, A., Blachford, C., Even‐Or, O., Joaquin, V. A., Briley-Saebo, K. C., Chen, W., Jiang, X., Mulder, W. J. M., Cormode, D. P., Fayad, Z. A., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400105j · Cited by 12 · see citing works
HDL as Bidirectional Lipid Vectors: Time for New Paradigms
Luna‐Luna, M., Niesor, E. J., & Pérez-Méndez, O. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051180 · Cited by 10 · see citing works
Apolipoprotein E3- and Nitric Oxide–Dependent Modulation of Endothelial Cell Inflammatory Responses
Mullick, A. E., Powers, A. F., Kota, R. S., Tetali, S. D., Eiserich, J. P., & Rutledge, J. C. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000253947.70438.99 · Cited by 7 · see citing works
Self-citationCheung, C.-L. (2009) · Research Online (University of Wollongong)
Who took apoA-I away from obese individuals?
Wang, S., & Peng, D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.106
Kwong, V. A. (2014) · TSpace (University of Toronto)
- Authors
- Olin-Lewis, K., Benton, J. L., Rutledge, J. C., Baskin, D. G., Wight, T. N., & Chait, A.
- Affiliations
- From the Departments of Medicine (K.O.-L., D.G.B., A.C.) and Pathology (T.N.W.), University of Washington, Seattle, Wash; and the Department of Medicine (J.L.B., J.C.R.), University of California, Davis, Calif. Present address for T.N.W. is The Hope Heart Institute, Seattle, Wash.
- University of Washington (US)
- Venue
- Circulation Research
- Published
- 2002-06-28
- Volume
- 90
- Issue
- 12
- Pages
- 1333-1339
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2163426832
- Cited by
- 19
- References
- 38
- Citations by year
- 2022: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL-18645, P01HL030086, HL3-0086, HL07028, P01HL018645, HL03045, T32HL007028)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456, DK07247, DK-17047, P30DK017047, T32DK007247)
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, high-density lipoprotein, vascular wall, carotid artery, arterial smooth muscle cells, extracellular matrix, proteoglycans, chondroitin sulfate, dermatan sulfate, atherogenesis, HDL binding, arginine residues
- MeSH terms
- Animals, Haplorhini, Apolipoproteins E, Arteries, Carotid Arteries, Cells, Cultured, Extracellular Matrix, Lipoproteins, HDL, Mice, Inbred C57BL, Microscopy, Fluorescence, Muscle, Smooth, Vascular, Proteoglycans, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review